Lilly to consider more acquisitions like $1.6 billion Armo buy
Eli Lilly and Co will consider more acquisitions similar to its $1.6 billion purchase of cancer drug developer Armo Biosciences earlier this year, the drugmaker’s chief financial officer said on...
Read More